$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Is Iressa covered by medical insurance?
2025-10-19 11:44:20
Check Details
Rubixetidine has significant effect in treating metastatic small cell lung cancer with low recurrence rate
2025-10-19 11:44:20
Check Details
How much does the new anti-cancer drug for lung cancer, Rubictidine, cost?
2025-10-19 11:44:20
Check Details
New drug Rybrevant brings the first targeted treatment for refractory lung cancer - Kanghule
2025-10-19 11:44:20
Check Details
Is Rybrevant, a new drug for non-small cell lung cancer, available in China?
2025-10-19 11:44:20
Check Details
Lumakras purchase method and price
2025-10-19 11:44:20
Check Details
The world's first KRAS targeted therapy-Lumakras
2025-10-19 11:44:20
Check Details
Medical insurance price of icotinib in 2021, how much does a box of icotinib cost after reimbursement
2025-10-19 11:44:20
Check Details
How much does Icotinib cost? How much does a box of Icotinib cost in 2021
2025-10-19 11:44:20
Check Details
How effective is Tarceva? Let lung cancer patients be their own heroes!
2025-10-19 11:44:20
Check Details
Which is better, vandetanib or cabozantinib? How to buy
2025-10-19 11:44:20
Check Details
Life cannot be without dreams, and lung cancer patients cannot live without crizotinib. Where can I buy cheap crizotinib?
2025-10-19 11:44:20
Check Details
1
2
...
3957
3958
3959
3960
3961
3962
3963
...
4164
4165
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
2
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
3
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
4
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
5
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
6
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
7
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
8
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
9
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
10
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
11
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
12
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits